The purpose of this study is to determine the efficacy and safety of Betahistine Mesilate in the treatment of patients with vertigo caused by Cerebral Infarction in posterior circulation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Beijing Hospital
Beijing, Beijing Municipality, China
Shanghai Renji Hospital
Shanghai, Shanghai Municipality, China
Shanghai Huashan Hospital
Shanghai, Shanghai Municipality, China
Changes in the European Evaluation of Vertigo (EEV) scale in 4 weeks.
Time frame: 4 weeks
The duration of the vertigo symptom.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.